These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 7822792)
1. Split tolerance in spleen chimeras. Sprent J; Hurd M; Schaefer M; Heath W J Immunol; 1995 Feb; 154(3):1198-206. PubMed ID: 7822792 [TBL] [Abstract][Full Text] [Related]
2. Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD. Sprent J; Schaefer M; Korngold R J Immunol; 1990 Apr; 144(8):2946-54. PubMed ID: 1969878 [TBL] [Abstract][Full Text] [Related]
3. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells. Thiele DL; Bryde SE; Lipsky PE J Immunol; 1988 Nov; 141(10):3377-82. PubMed ID: 3053897 [TBL] [Abstract][Full Text] [Related]
4. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice. Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050 [TBL] [Abstract][Full Text] [Related]
5. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice. Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296 [TBL] [Abstract][Full Text] [Related]
6. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules. Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147 [TBL] [Abstract][Full Text] [Related]
7. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides. Leibnitz RR; Lipsky PE; Thiele DL J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234 [TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777 [TBL] [Abstract][Full Text] [Related]
9. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease. Leibnitz RR; Lipsky PE; Thiele DL J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559 [TBL] [Abstract][Full Text] [Related]
10. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. Brochu S; Baron C; Hétu F; Roy DC; Perreault C J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519 [TBL] [Abstract][Full Text] [Related]
11. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. Moser M; Sharrow SO; Shearer GM J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615 [TBL] [Abstract][Full Text] [Related]
12. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. Drobyski WR; Majewski D; Hanson G Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102 [TBL] [Abstract][Full Text] [Related]
14. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round. Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962 [TBL] [Abstract][Full Text] [Related]
15. B cell-induced tolerance to class II MHC antigens in the chicken. Lehtonen L; Vainio O; Veromaa T; Toivanen P Transplantation; 1989 Oct; 48(4):646-50. PubMed ID: 2529681 [TBL] [Abstract][Full Text] [Related]
16. Tolerance to class I major histocompatibility complex antigens in chicken B cell chimeras. Effect of B cell depletion on transferability of tolerance. Lehtonen L; Vainio O; Veromaa T; Toivanen P Eur J Immunol; 1989 Mar; 19(3):425-31. PubMed ID: 2523310 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function. Via CS; Shanley JD; Shearer GM J Immunol; 1990 Nov; 145(10):3283-9. PubMed ID: 2172381 [TBL] [Abstract][Full Text] [Related]
18. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
19. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Berger M; Wettstein PJ; Korngold R Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395 [TBL] [Abstract][Full Text] [Related]
20. The mechanism of graft-host-tolerance in murine radiation chimeras transplanted across minor histocompatibility barriers. Perreault C; Bélanger R; Gyger M; Allard A; Brochu S Bone Marrow Transplant; 1989 Jan; 4(1):83-7. PubMed ID: 2647191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]